alg,clNo,clustsize,no.Trubetskoy Broad,Enrichment,Broad pval,Broad padj,no. Trubetskoy Priortised,Prior pval,Prior padj,Molecular Function,Molecular padj,Biological Function,Biological padj,Diseases,Diseases padj
sgG5,116.0,33.0,5.0,Positive,0.0087396424758193,0.0174792849516386,0,0,0,"['DNA-binding transcription factor binding', 'nuclear receptor binding', 'histone deacetylase binding', 'chromatin DNA binding', 'chromatin binding', 'transcription cis-regulatory region binding', 'transcription coactivator binding', 'transcription corepressor activity', 'transcription coactivator activity', 'histone acetyltransferase activity', 'RNA polymerase II cis-regulatory region sequence-specific DNA binding', 'RNA polymerase II transcription regulatory region sequence-specific DNA binding', 'peptide N-acetyltransferase activity', 'histone H3K9me/H3K9me2 demethylase activity', 'DNA-binding transcription factor activity', 'peptide-lysine-N-acetyltransferase activity', 'NF-kappaB binding', 'DNA binding', 'RNA polymerase II-specific DNA-binding transcription factor binding', 'histone H3K9 demethylase activity', 'nuclear receptor coactivator activity', 'DNA-binding transcription activator activity, RNA polymerase II-specific', 'protein lysine deacetylase activity', 'nuclear glucocorticoid receptor binding', 'nuclear retinoid X receptor binding', 'histone acetyltransferase binding', 'sequence-specific double-stranded DNA binding']","[5.05836526616212e-08, 9.18138639135872e-07, 3.17268076322884e-06, 1.66334471426315e-05, 2.11595348867646e-05, 6.17176288399411e-05, 0.000131444830024, 0.0006163847287508, 0.0039322280504412, 0.0055426024072091, 0.0055426024072091, 0.0068566616889805, 0.0081154737789423, 0.0081154737789423, 0.0120714642353605, 0.0212121737301436, 0.0220272667532304, 0.0220272667532304, 0.0221346418240171, 0.0337946425148653, 0.0423761653776032, 0.0431416413696245, 0.0431416413696245, 0.0431416413696245, 0.0431416413696245, 0.0431416413696245, 0.0494632446759514]","['negative regulation of transcription by RNA polymerase II', 'positive regulation of transcription by RNA polymerase II', 'toll-like receptor 4 signaling pathway', 'circadian regulation of gene expression', 'chromatin remodeling', 'locomotor rhythm', 'negative regulation of miRNA transcription', 'canonical NF-kappaB signal transduction', 'non-canonical NF-kappaB signal transduction', 'cellular response to angiotensin', 'negative regulation of DNA-templated transcription', 'interleukin-1-mediated signaling pathway', 'stimulatory C-type lectin receptor signaling pathway', 'N-terminal peptidyl-lysine acetylation', 'nucleotide-binding oligomerization domain containing 2 signaling pathway', 'cellular response to peptidoglycan', 'TRIF-dependent toll-like receptor signaling pathway', 'positive regulation of interleukin-1 beta production', 'regulation of transcription by RNA polymerase II', 'regulation of DNA-templated transcription', 'tumor necrosis factor-mediated signaling pathway', 'positive regulation of DNA-templated transcription', 'cellular response to lipoteichoic acid']","[2.79442860489282e-07, 4.15094188170896e-07, 0.0001637392895168, 0.001267753509565, 0.0027803595004736, 0.0032512214939193, 0.0032512214939193, 0.0078916325078449, 0.0078916325078449, 0.0078916325078449, 0.0087224131327916, 0.0104732903782369, 0.0202872078313702, 0.0202872078313702, 0.0202872078313702, 0.0202872078313702, 0.0202872078313702, 0.0202872078313702, 0.0216325227504217, 0.0274417205952117, 0.0378294599517482, 0.0463001318432958, 0.0465908220880798]",[],[]
sgG5,112.0,26.0,4.0,Positive,0.0177423562365708,0.0354847124731416,0,0,0,[],[],[],[],"['multiple_sclerosis', 'schizophrenia']","[0.0434132565571266, 0.0462553781312736]"
